Glucagon Receptor
Glucagon receptors are GPCRs that mediate the effects of glucagon, a hormone involved in regulating glucose homeostasis by promoting glycogen breakdown and glucose release from the liver. These receptors are critical in the management of blood sugar levels and are of particular interest in the study of diabetes and metabolic disorders. Glucagon receptor antagonists are being explored as potential treatments for hyperglycemia in type 2 diabetes. At CymitQuimica, we offer a variety of high-quality glucagon receptor modulators to support your research in endocrinology, diabetes, and metabolic regulation.
Found 216 products for "Glucagon Receptor".
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
PF-06882961
CAS:PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist.Formula:C31H30FN5O4Purity:97.19% - 99.56%Color and Shape:SolidMolecular weight:555.60Tirzepatide monosodium salt
Tirzepatide sodium salt (LY3298176 sodium salt) is a GIP and GLP-1 receptor agonist with neuroprotective activity and can be used to treat obesity.Formula:C225H347N48O68NaPurity:99.69%Color and Shape:SolidMolecular weight:4835.51Avexitide acetate
CAS:Avexitide acetate (exendin 9-39) is a potent glucagon-like peptide 1 receptor (GLP-1R) antagonist for the study of post-obesity hypoglycemia.Formula:C155H246N40O53SPurity:96.64% - 98.65%Color and Shape:SolidMolecular weight:3549.91Glucagon (1-29), bovine, human, porcine hydrochloride
CAS:Glucagon (1-29), bovine, human, porcine hydrochloride is a peptide hormone, produced by pancreatic α-cells. Glucagon increases HNF4α phosphorylation.Formula:C153H226ClN43O49SPurity:95.65% - 99.33%Color and Shape:SolidMolecular weight:3519.208Crotedumab
CAS:Crotedumab (REGN1193) is a humanized antibody targeting GCGR, which reduces fasting blood glucose and improves glucose tolerance, used in diabetes research.Purity:>95%Color and Shape:LiquidMolecular weight:146.82 kDa (Predicted)Volagidemab
CAS:Anti-CD34 Antibody is a CHO-expressed humanized monoclonal antibody targeting CD34, which can be used for the study of neurological and cardiovascular diseases.Purity:97.8% (SDS-PAGE); 98% (SEC-HPLC) - 97.8% (SDS-PAGE); 98% (SEC-HPLC)Color and Shape:Transparent LiquidMolecular weight:147 kDa (Predicted)GLP-1 receptor agonist 18
CAS:GLP-1 receptor agonist 18 is an orally active GLP-1 receptor agonist with an EC50 of 0.22 nM. It effectively reduces blood glucose levels and body weight, making it useful for diabetes research.Formula:C50H52F2N10O5Molecular weight:911.01V-0219 hydrochloride
V-0219 hydrochloride: oral GLP-1R PAM for obesity-linked diabetes study.Formula:C20H26ClF3N4O2Purity:99.97%Color and Shape:SoildMolecular weight:446.89GLP-1 moiety from Dulaglutide
GLP-1 moiety from Dulaglutide is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist.Formula:C149H221N37O49Purity:98%Color and Shape:SolidMolecular weight:3314.62Pemvidutide
CAS:Pemvidutide: GLP-1R/GCGR agonist; reduces body weight, liver fat, serum lipids; for NASH, obesity studies.Formula:C182H275N39O54Molecular weight:3873.35Anti-Human GLP-1R Antibody
Anti-GLP-1R Antibody is an anti-GLP-1R antibody that can be used for immunohistochemistry of paraffin sections.Purity:98.3% (SDS-PAGE); 97.2% (SEC-HPLC) - 98.3% (SDS-PAGE); 97.2% (SEC-HPLC)Color and Shape:Odour LiquidMolecular weight:144.48 kDa (Predicted)Mazdutide
CAS:Mazdutide (OXM-3) is a dual agonist of the glucagon and GLP-1 receptors, belonging to the incretin category, and can be used in research related to obesity and type 2 diabetes, including studies on body weight regulation and blood glucose control.Formula:C210H322N46O67Molecular weight:4563.06Exendin-4, Cy5 labeled TFA
Exendin-4, Cy5 labeled TFA is a Cy5-tagged version of Exendin 4. It serves as an in vivo β-cell tracer. Exendin 4 is a long-acting GLP-1 receptor agonist.PROTAC G9a/GLP degrader 1
PROTACG9a/GLP degrader 1 is a G9a/GLP PROTAC degrader with a DC50 of 336 nM for G9a and 988 nM for GLP. It exhibits inhibitory activity against G9a with an IC50 of 98 nM. This compound effectively inhibits the migration of breast cancer MCF-7 cells without affecting their proliferation and is utilized in breast cancer research.Apraglutide acetate
Apraglutide acetate is a stable GLP-2 receptor agonist that promotes intestinal growth and is used in GI research.Formula:C172H263N43O52·xC2H2O2Purity:99.96%Molecular weight:3765.25(free base)Tirzepatide
CAS:Tirzepatide (LY-3298176) is a dual glucose-dependent polypeptide (GIP) (EC50=0.042 nM) and glucagon-like peptide-1 (GLP-1) (EC50=0.086 nM) receptor agonist.Formula:C225H348N48O68Purity:99.52% - 99.99%Color and Shape:White SolidMolecular weight:4813.45GEP12
GEP12 is a tri-receptor agonist peptide targeting GLP-1R, Y1-R, and Y2-R, with an EC50 of 17.3 nM as a GLP-1R agonist and an IC50 of 19.2 nM for binding to the receptor. GEP12 can aid in blood glucose management and weight reduction.Color and Shape:Odour SolidGLP-1R-agonist-43
CAS:GLP-1R-agonist-43 (Compound A) is an orally active GLP-1R agonist with an EC50 of 2.68 nM. It is useful in research related to non-insulin-dependent diabetes (type 2 diabetes) and obesity.Formula:C54H56FN9O6Molecular weight:946.08GLP-1R Antagonist 1
CAS:GLP-1R Antagonist 1 is an orally active, CNS penetrant and non-competitive glucagon-like peptide 1 receptor (GLP-1R) antagonist (IC50: 650 nM).Formula:C16H11ClF6N4O2Purity:99.84%Color and Shape:White SolidMolecular weight:440.728Liraglutide-D8 tetraTFA
Liraglutide-D8 tetraTFA is the deuterated form of Liraglutide. Liraglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist and is utilized in the study of type 2 diabetes.
